Chemed (CHE) Competitors

Amedisys (NASDAQ:AMED) and Chemed (NYSE:CHE) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability.

Do insiders and institutionals hold more shares of AMED or CHE?

94.4% of Amedisys shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 1.8% of Amedisys shares are owned by company insiders. Comparatively, 4.0% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Do analysts recommend AMED or CHE?

Amedisys presently has a consensus target price of $97.50, suggesting a potential upside of 7.87%. Chemed has a consensus target price of $681.00, suggesting a potential upside of 13.50%. Given Amedisys' stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Amedisys.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amedisys	0 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.13
Chemed	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility & risk, AMED or CHE?

Amedisys has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500.

Is AMED or CHE more profitable?

Chemed has a net margin of 12.03% compared to Chemed's net margin of -0.44%. Amedisys' return on equity of 32.29% beat Chemed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amedisys	-0.44%	12.76%	7.02%
Chemed	12.03%	32.29%	20.74%

Does the MarketBeat Community believe in AMED or CHE?

Amedisys received 166 more outperform votes than Chemed when rated by MarketBeat users. However, 63.44% of users gave Chemed an outperform vote while only 59.02% of users gave Amedisys an outperform vote.

Company	Underperform	Outperform
Amedisys	Outperform Votes 494 59.02%	Underperform Votes 343 40.98%
Chemed	Outperform Votes 328 63.44%	Underperform Votes 189 36.56%

Which has stronger earnings & valuation, AMED or CHE?

Chemed has higher revenue and earnings than Amedisys. Amedisys is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amedisys	$2.24B	1.32	-$9.75M	-$0.31	-291.89
Chemed	$2.26B	4.00	$272.51M	$17.92	33.43

Does the media prefer AMED or CHE?

In the previous week, Amedisys and Amedisys both had 4 articles in the media. Chemed's average media sentiment score of 1.82 beat Amedisys' score of 0.85 indicating that Amedisys is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amedisys	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Chemed	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Chemed beats Amedisys on 14 of the 17 factors compared between the two stocks.